Related Experiment Video
Updated: Mar 11, 2026

Acquisition of Resting-State Functional Magnetic Resonance Imaging Data in the Rat
Published on: August 28, 2021
Prolonged Infusion of Dexmedetomidine in Critically-ill Children
Cinara Andreolio1, Jefferson Pedro Piva, Elisa Baldasso
1Pediatric Intensive Care Unit at Hospital de Clinicas de Porto Alegre and Pediatric Emergency and Intensive Care Department Medical School UFRGS University, Brazil. Correspondence to: Cinara Andreolio Rua Ramiro Barcelos, 2350 Zip Code 90035003. cinarandreolio@hotmail.com.
Insights
Dexmedetomidine is a safe sedative for critically ill children, showing few side effects during mechanical ventilation weaning and post-surgery care. This study highlights its use in pediatric intensive care units.
Area of Science:
- Pediatric Critical Care Medicine
- Pharmacology
- Sedation Management
Background:
- Dexmedetomidine is increasingly used for sedation in pediatric intensive care units (PICUs).
- Understanding its indications, dosing, and side effect profile is crucial for safe administration.
Purpose of the Study:
- To describe the main indications, doses, infusion duration, and side effects of dexmedetomidine.
- To evaluate the safety and efficacy of dexmedetomidine in critically ill children.
Main Methods:
- Observational and retrospective study design.
- Evaluation of dexmedetomidine use in a pediatric intensive care unit.
- Analysis of data from 77 children receiving dexmedetomidine infusions.
Main Results:
- Dexmedetomidine was used for mechanical ventilation weaning (32.5%), post-neurosurgery/airway surgery (24.7%), non-invasive ventilation (13%), and refractory tachycardia (6.5%).
- A significant decrease in mean arterial pressure and heart rate was observed after 6 hours of infusion.
- Eight percent of children experienced side effects (hypotension, bradycardia, somnolence), leading to drug withdrawal.
Conclusions:
- Dexmedetomidine can be safely used as a sedative in critically ill children.
- The drug demonstrates a favorable side effect profile when used appropriately in the pediatric intensive care setting.
Objective:
To describe main indications, doses, length of infusion and side effects related to dexmedetomidine infusion.
Methods:
Observational and retrospective study evaluating dexmedetomidine use in pediatric intensive care unit.
Results:
77 children received dexmedetomidine infusion longer than 6 hours for mechanical ventilation weaning (32.5%), post- neurosurgery and post-upper airway surgery (24.7%), non-invasive ventilation (13%), refractory tachycardia (6.5%) and other causes (23.3%). After 6 hours of infusion, significant decrease in mean arterial pressure and heart rate was observed in all groups. Six children (8%) required withdrawal of drug because of possible side effects: hypotension, bradycardia and somnolence.
Conclusion:
Dexmedetomidine may be used as sedative in critically ill children without much side effects.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Parenteral Anesthetics: Overview
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
IV Infusion to Oral Dosing: Conversion Methods

